We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Antenatal Relaxation Group for Anxiety and Depression Management (ARG)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2009 by University of Saskatchewan.
Recruitment status was:  Enrolling by invitation
ClinicalTrials.gov Identifier:
First Posted: March 4, 2009
Last Update Posted: March 18, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Royal University Hospital Foundation, Saskatoon, SK, Canada
Information provided by:
University of Saskatchewan

Approximately 20% of pregnant women experience depression. Untreated depression during pregnancy is linked to decreased prenatal care, difficulties in the pregnancy, poorer outcomes for the baby, and developmental, language, and behaviour problems in the older child.

While medication can often offer relief, pregnant women suffering with depression are often reluctant to take medications that may affect the unborn baby. There is little research about the effectiveness of other treatments such as support groups.

The investigators project will provide relaxation groups for pregnant women with anxiety and depression. The group will provide a chance to get support from other pregnant women. Two health care specialists will provide information about anxiety and depression. They will also teach the skills for women to manage their symptoms. Women will be asked to complete a few questionnaires to evaluate their symptoms before, during, and after they join the group. They will also be asked to evaluate how the group met their needs.

Condition Intervention
Anxiety Depression Behavioral: mindful meditation Behavioral: interpersonal therapy

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Antenatal Depression Group Research Project: The Effectiveness of Mindfulness-based Relaxation and Interpersonal Therapy to Relieve Anxiety and Depression Symptoms in Pregnant Women.

Resource links provided by NLM:

Further study details as provided by University of Saskatchewan:

Primary Outcome Measures:
  • Depression as measured by Edinburgh Postnatal Depression Scale and anxiety as measured by the State-Trait Anxiety Inventory and the Cambridge Worry Scale [ Time Frame: Participants will be asked to complete the questionnaires before the group commences, at 4 weeks, at the end of the group, and 6 weeks postpartum. ]

Estimated Enrollment: 20
Study Start Date: October 2008
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: mindfulness-based therapy
mindfulness-based meditation
Behavioral: mindful meditation
interpersonal and psycho-educational
Experimental: interpersonal therapy
Behavioral: interpersonal therapy

Detailed Description:

Pregnant women between 15-28 weeks, who speak english are invited to join an 8 week group to relieve anxiety and depression.

We have collected sociodemographic data, as well as social support, life events.

Outcome measures are a decrease in anxiety and depression-as measured by the Edinburgh Postnatal Depression Scale, the Cambridge Worry Scale, and the STAI-Trait Scale.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   16 Years to 60 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 15 to 28 weeks pregnant and English speaking

Exclusion Criteria:

  • Non-English speaking
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00855192

Canada, Saskatchewan
Saskatoon Community Village
Saskatoon, Saskatchewan, Canada, S7K 4A7
University of Saskatchewan Department of Psychiatry
Saskatoon, Saskatchewan, Canada, S7N 0W8
Sponsors and Collaborators
University of Saskatchewan
Royal University Hospital Foundation, Saskatoon, SK, Canada
Principal Investigator: Angela N Bowen, PhD University of Saskatchewan
  More Information

Additional Information:
Responsible Party: Angela Bowen, RN, PhD Assistant Professor, College of Nursing, College of Medicine, Department of Psychiatry, University of Saskatchewan
ClinicalTrials.gov Identifier: NCT00855192     History of Changes
Other Study ID Numbers: Beh #07-10
First Submitted: March 2, 2009
First Posted: March 4, 2009
Last Update Posted: March 18, 2010
Last Verified: March 2009

Keywords provided by University of Saskatchewan:
mindfulness-based therapy
interpersonal therapy
support groups

Additional relevant MeSH terms:
Depressive Disorder
Anxiety Disorders
Behavioral Symptoms
Mood Disorders
Mental Disorders